Fcf Advisors LLC Exelixis, Inc. Transaction History
Fcf Advisors LLC
- $695 Million
- Q2 2025
A detailed history of Fcf Advisors LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Fcf Advisors LLC holds 142,813 shares of EXEL stock, worth $5.28 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
142,813Holding current value
$5.28 Million% of portfolio
0.91%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
643Shares Held
257MCall Options Held
1.67MPut Options Held
733K-
Black Rock Inc. New York, NY33.5MShares$1.24 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.06 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$832 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$548 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$436 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.9B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...